Innovative Surgical Platform Levita Magnetics offers the proprietary MARS® platform, a first-of-its-kind Medical Magnetic Assistance System designed to reduce surgical footprint and enhance patient outcomes, presenting a compelling solution for healthcare providers seeking minimally invasive surgery options.

Growth and Financing With recent Series C funding of $26 million and a track record of launching multiple surgical procedures, Levita demonstrates strong growth momentum and financial stability, making it an attractive partner for strategic collaborations and expanding market reach.

Market Expansion Opportunities Levita’s focus on regulatory efforts and US commercial deployment signals ongoing efforts to penetrate hospital networks and surgical centers, suggesting potential sales opportunities with healthcare institutions adopting innovative advanced surgical technologies.

Clinical Evidence & Validation Publication of clinical data and milestone procedures indicate Levita’s commitment to evidence-based medicine, which can facilitate sales discussions emphasizing safety, efficacy, and improved patient outcomes to clinical decision-makers.

Strong Silicon Valley Presence Headquartered in Silicon Valley with a team of clinicians and engineers, Levita’s innovative mindset combined with technological expertise provides opportunities to engage with cutting-edge medical professionals and early adopters of surgical technology.